drug protocol number

RJ19/119/J

drug sponsor

King Abdullah International Medical Research Center’s (KAIMRC)

drug study

Brentuximab Vedotin + AVD (Adriamycin, Vinblastine & Dacarbazine

drug trial site

King Abdullah Medical Complex (Jeddah)

drug status

Ongoing

drug phase